Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1970 3
1971 2
1972 1
1973 1
1974 1
1975 2
1976 2
1978 2
1979 1
1981 1
1982 1
1983 4
1984 4
1985 5
1986 7
1987 10
1988 14
1989 4
1990 4
1991 4
1992 3
1993 2
1994 5
1995 5
1996 13
1997 6
1998 10
1999 8
2000 9
2001 16
2002 21
2003 14
2004 21
2005 11
2006 15
2007 17
2008 14
2009 20
2010 18
2011 39
2012 48
2013 45
2014 53
2015 27
2016 36
2017 36
2018 32
2019 25
2020 36
2021 45
2022 29
Text availability
Article attribute
Article type
Publication date

Search Results

674 results
Results by year
Filters applied: . Clear all
Page 1
Consensus on the key characteristics of endocrine-disrupting chemicals as a basis for hazard identification.
La Merrill MA, Vandenberg LN, Smith MT, Goodson W, Browne P, Patisaul HB, Guyton KZ, Kortenkamp A, Cogliano VJ, Woodruff TJ, Rieswijk L, Sone H, Korach KS, Gore AC, Zeise L, Zoeller RT. La Merrill MA, et al. Among authors: sone h. Nat Rev Endocrinol. 2020 Jan;16(1):45-57. doi: 10.1038/s41574-019-0273-8. Epub 2019 Nov 12. Nat Rev Endocrinol. 2020. PMID: 31719706 Free PMC article. Review.
Hepatocyte ELOVL Fatty Acid Elongase 6 Determines Ceramide Acyl-Chain Length and Hepatic Insulin Sensitivity in Mice.
Matsuzaka T, Kuba M, Koyasu S, Yamamoto Y, Motomura K, Arulmozhiraja S, Ohno H, Sharma R, Shimura T, Okajima Y, Han SI, Aita Y, Mizunoe Y, Osaki Y, Iwasaki H, Yatoh S, Suzuki H, Sone H, Takeuchi Y, Yahagi N, Miyamoto T, Sekiya M, Nakagawa Y, Ema M, Takahashi S, Tokiwa H, Shimano H. Matsuzaka T, et al. Among authors: sone h. Hepatology. 2020 May;71(5):1609-1625. doi: 10.1002/hep.30953. Epub 2020 Feb 7. Hepatology. 2020. PMID: 31529722
A 52-week randomized controlled trial of ipragliflozin or sitagliptin in type 2 diabetes combined with metformin: The N-ISM study.
Kitazawa M, Katagiri T, Suzuki H, Matsunaga S, H Yamada M, Ikarashi T, Yamamoto M, Furukawa K, Iwanaga M, Hatta M, Fujihara K, Yamada T, Tanaka S, Sone H. Kitazawa M, et al. Among authors: sone h. Diabetes Obes Metab. 2021 Mar;23(3):811-821. doi: 10.1111/dom.14288. Epub 2021 Jan 8. Diabetes Obes Metab. 2021. PMID: 33416200 Free PMC article. Clinical Trial.
Oxygenomics in environmental stress.
Sone H, Akanuma H, Fukuda T. Sone H, et al. Redox Rep. 2010;15(3):98-114. doi: 10.1179/174329210X12650506623843. Redox Rep. 2010. PMID: 20594413 Free PMC article. Review.
Does a Drug-Coated Balloon Accelerate Neoatherosclerosis?
Mori H, Sone H, Wada D, Takei Y, Tashiro K, Sasai M, Sato T, Suzuki H. Mori H, et al. Among authors: sone h. CJC Open. 2020 Mar 12;2(4):306-307. doi: 10.1016/j.cjco.2020.03.002. eCollection 2020 Jul. CJC Open. 2020. PMID: 32695981 Free PMC article. No abstract available.
Accuracy of Japanese claims data in identifying diabetes-related complications.
Fujihara K, Yamada-Harada M, Matsubayashi Y, Kitazawa M, Yamamoto M, Yaguchi Y, Seida H, Kodama S, Akazawa K, Sone H. Fujihara K, et al. Among authors: sone h. Pharmacoepidemiol Drug Saf. 2021 May;30(5):594-601. doi: 10.1002/pds.5213. Epub 2021 Mar 4. Pharmacoepidemiol Drug Saf. 2021. PMID: 33629363
The Japanese Medical Science Federation COVID-19 Expert Opinion English Version.
Nangaku M, Kadowaki T, Yotsuyanagi H, Ohmagari N, Egi M, Sasaki J, Sakamoto T, Hasegawa Y, Ogura T, Chiba S, Node K, Suzuki R, Yamaguchi Y, Murashima A, Ikeda N, Morishita E, Yuzawa K, Moriuchi H, Hayakawa S, Nishi D, Irisawa A, Miyamoto T, Suzuki H, Sone H, Fujino Y. Nangaku M, et al. Among authors: sone h. JMA J. 2021 Apr 15;4(2):148-162. doi: 10.31662/jmaj.2021-0002. Epub 2021 Apr 8. JMA J. 2021. PMID: 33997449 Free PMC article.
674 results